Lisinopril/hydrochlorothiazide: Difference between revisions
Content deleted Content added
Anypodetos (talk | contribs) |
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/Dr |
||
| Line 1: | Line 1: | ||
{{Drugbox |
{{Drugbox |
||
| verifiedrevid = |
| verifiedrevid = 447439314 |
||
<!--Combo data--> |
<!--Combo data--> |
||
Revision as of 15:22, 10 September 2011
| Combination of | |
|---|---|
| Lisinopril | ACE inhibitor |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| MedlinePlus | a601070 |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| (verify) | |
Lisinopril/hydrochlorothiazide (trade name Prinzide by Merck & Co., Zestoretic by AstraZeneca, and many others) is a combination of the drugs lisinopril, an ACE inhibitor, and hydrochlorothiazide, a diuretic. It is used to control hypertension.
References
- Drugs.com: Prinzide
- Drugs.com: Zestoretic
 | This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |